Advertisement

Topics

Pathologic complete response to neoadjuvant therapy in certain breast cancer patients predicts low risk for local metastases

12:28 EDT 19 Apr 2017 | ecancermedicalscience

Select breast cancer patients who achieved pathologic complete response (pCR) after chemotherapy may be able to avoid follow-up breast and lymph node, or axillary, surgery, according to new findings from researchers at The University of Texas MD Anderson...

Original Article: Pathologic complete response to neoadjuvant therapy in certain breast cancer patients predicts low risk for local metastases

NEXT ARTICLE

More From BioPortfolio on "Pathologic complete response to neoadjuvant therapy in certain breast cancer patients predicts low risk for local metastases"

Quick Search
Advertisement
 

Relevant Topics

Polymerase Chain Reaction (PCR)
PCR (Polymerase Chain Reaction) uses the ability of DNA polymerase (enzymes that create DNA molecules by assembling nucleotides, the building blocks of DNA. These enzymes are essential to DNA replication and usually work in pairs to create two ident...

Breast Cancer
Track and monitor developments in breast cancer research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...